4//SEC Filing
VERTEX PHARMACEUTICALS INC / MA 4
Accession 0001209191-14-069989
$VRTXCIK 0000875320operating
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:14 PM ET
Size
5.8 KB
Accession
0001209191-14-069989
Insider Transaction Report
Form 4
Connolly Thomas
SVP, Human Resources
Transactions
- Sale
Common Stock
2014-11-17$111.87/sh−153$17,116→ 34,895 total
Holdings
- 150(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $111.87 (range $111.85 to $111.88).
- [F3]Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000875320
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:14 PM ET
- Size
- 5.8 KB